COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Coronavirus Guidance for NIH Applicants and Grantees: https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

IRG Summary

EMNR will evaluate applications on basic and clinical aspects of hypothalamic, pituitary, gonadal, thyroid, and adrenal physiology and pathophysiology, diabetes mellitus (including its pathogenesis, complications and treatment), the biology of the pancreatic islet (beta cell), adipocyte biology, obesity (including its causes and treatment), and other metabolic disorders including inborn errors of metabolism and nutrient transport disorders.  Also reviewed in this IRG are applications addressing the biology of reproduction and the pathobiology of its disorders (including the causes and treatments of infertility); male and female reproductive aging and menopause; obstetrical disorders of implantation, gestation, embryogenesis, and parturition; disorders of fetal and neonatal life; and gynecologic conditions are reviewed in this IRG.  Studies of the role of nutrition under normal and pathological conditions are also reviewed in this IRG.

Study Sections




Applications

  • This IRG reviews applications involving integrative physiology and pathophysiology such as neuroendocrinology; humoral actions on the gut, lung and heart; cancers of the endocrine glands; as well as studies related to the effects and mechanisms of action of drugs, biopharmaceuticals, alcohol and toxicants, xenobiotics and endobiotics on reproduction or on endocrine glands.
  • Applications reviewed in this IRG may propose a broad range of basic or clinical research methods and techniques, including pharmacologic, chemical and biochemical approaches, genetics, genomics and proteomics, molecular and cell biology techniques, animal models, and patient-oriented studies involving these research topics mentioned above.